Myc on my mind: a transcription factor family's essential role in brain development by Mainwaring, Lori A. et al.
 
www.impactjournals.com/oncotarget/             Oncotarget, June 2010, Vol. 1, No 2 
 
  
www.impactjournals.com/oncotarget       86                             Oncotarget 2010; 1: 86-88 
Researchers have been captivated by the myc family 
of proto-oncogenes and their ability to regulate a diverse 
array of cellular processes through transcriptional 
regulation of target genes.  Since the early 1980s 
researchers have worked to understand how Myc family 
members regulate hundreds of genes in a context-
dependent and cell type-specific manner.  Gene 
expression profiling performed in various over-
expression platforms have identified hundreds of genes 
regulated by Myc but have done little to narrow the focus 
of Myc’s function as the genes typically fall into multiple 
biological categories, including protein biosynthesis, 
metabolism, cell cycle regulation and microRNAs [1, 2].  
In order to parse the cell type-specific function of Myc 
proteins, future studies will benefit from the generation 
of mouse models wherein gene manipulation can be 
restricted to specific cell types.  
Mammals possess three closely related myc family 
members: c-, N-, and L-myc, which have 
developmentally regulated, tissue specific expression 
patterns.  These proteins, basic-helix-loop-helix zipper 
(bHLHZ) transcription factors, heterodimerize with the 
ubiquitously-expressed Max protein to activate gene 
expression.  In complex with another protein, Miz1, myc 
may suppress gene expression [3, 4].  Myc has been 
predicted with gene promoters, including those that 
control cell cycle regulation, apoptosis, differentiation 
programs as well as chromatin remodeling [1, 5].  More 
recently Myc proteins have also been shown to regulate 
genes involved in ribosome biosynthesis and other 
components involved in protein translation [6], 
suggesting that Myc’s roles in cellular processes extend 
beyond cell cycle and apoptosis regulation.  Furthermore, 
Myc’s ability to cooperate with three other transcription 
factors (Oct4, Sox2 and Klf4) to reprogram somatic cells 
to induced pluripotent stem cells suggests Myc proteins 
have critical roles in maintaining cells in an 
undifferentiated state [7, 8].  
The role for Myc proteins in proliferation has been 
well  documented in mammals through embryonic and 
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Fig. Myc controls multiple signaling pathways 
Myc proteins increase euchromatin levels, which is 
associated  with gene transcription and the 
induction of metabolism, ribosome biogenesis, and 
protein synthesis, resulting in cellular proliferation, 
growth, survival, and stem cell self -renewal. Loss 
or suppression of Myc changes heterochromatin 
levels, which leads to the suppression of 
transcription and ribosome biogenesis and protein 
synthesis, resulting in cell-cycle arrest, 
differentiation, and cell adhesion.  
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conditional knockout mouse models.  c-myc is expressed 
widely in the mouse embryo and expression patterns 
correlate to rapidly proliferating cells [9].  Accordingly, 
constitutive c-myc knockout mice do not survive past 
embryonic day (E) 10.5 due to an overall reduced size, 
enlarged hearts, and a failure in neural tube closure [10].  
N-myc expression on the other hand, is restricted 
primarily to epithelial tissues especially those of the 
developing nervous system.  Homozygous N-myc mutant 
embryos die around E11.5 as a result of defects in the 
central and peripheral nervous system as well as poorly 
developed lung and gut tissue [11].  Because of 
embryonic lethality of c-  and N-myc null mice, tissue 
specific deletions of Myc genes have been generated and 
proved to be usefully in demonstrating the importance of 
these genes in proliferation, which is illustrated by c-myc 
loss in hematopoietic cells [12, 13].  
The role of N-myc in neural progenitor cells has been 
characterized by targeted deletion of the gene in Nestin-
expressing cells.  In addition to overall brain growth 
defects, the authors observed profound disruptions in 
cerebellar development as a consequence of reduced 
numbers of neural progenitors cells and decreased 
proliferation rates in cerebellar precursor cells [14].   
Interestingly knockout of c-myc in neural progenitors 
resulted in only moderate growth defects [14, 15].  Taken 
together these single myc gene conditional knockout 
models suggest that c-myc and N-myc have 
compensatory roles but also have individual functions 
that are important in the developing nervous system. 
In order to dissect out how c-myc and N-myc 
cooperate to promote neural development, Wey and 
Knoepfler deleted both genes in Nestin-expressing neural 
precursor cells.  The double knock-out (DKO) mice had 
a more severe phenotype compared to the single Myc 
gene conditional knockouts and the growth defects were 
predominately observed in the forebrain/neocortex and 
hindbrain.  The growth defects were determined to be a 
result of decreased mitotically active cells as well as a 
failure of progenitor cells in the subventricular and 
ventricular zone to initiate differentiation programs. 
Surprisingly, gene expression profiling from the DKO 
mouse brains revealed modest levels of changes in gene 
expression compared to controls; however, specific 
patterns of changes were observed based on ontological 
analysis of the genes that were significantly altered.  A 
cluster of mitosis-related genes was significantly down-
regulated in the DKO mice further indicating a critical 
role for myc genes in neural progenitor proliferation.   
Consistent with previous studies, genes involved in 
cellular metabolism and ribosome biogenesis were also 
affected in DKO mice [16, 17].  The characterization and 
analysis of the DKO mice confirm the importance of 
Myc activity in neural precursor proliferation and 
identify potential Myc targets that may function to 
regulate multiple cellular processes.  However, further 
studies will be required to validate the candidate 
regulated genes as bona fide myc targets, as well as 
additional mechanistic analysis to verify the roles of myc 
in the biological processes proposed to comprise the myc 
transcriptional program during brain development.  
The report by Wey and Knoepfler sheds light into the 
role of myc genes in the developing nervous system but 
also reveals a useful, important genetic tool for studying 
myc gene targets in the context of specific brain regions 
or cellular processes.  The mice harboring conditionally 
ablatable c- and/or N-myc will be amenable to in vitro 
studies of primary neural precursors, neural stem cells, 
and brain slice explants which can then be exposed to 
Cre recombinase-carrying vectors, for example, to 
provide insight into the mechanisms by which myc 
regulates neural progenitor proliferation and 
differentiation.  Furthermore the DKO mice will be 
useful in conjunction with the single myc gene 
conditional KO mice to look at differences in gene 
expression profiles and for identification of gene sets 
critical for proliferation, cell growth, or differentiation in 
the context of tumors arising from neural stem/progenitor 
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